115 related articles for article (PubMed ID: 25683632)
1. Long term trends in oral antidiabetic drug use among children and adolescents in the Netherlands.
Fazeli Farsani S; Souverein PC; Overbeek JA; van der Vorst MM; Knibbe CA; Herings RM; de Boer A; Mantel-Teeuwisse AK
Br J Clin Pharmacol; 2015 Aug; 80(2):294-303. PubMed ID: 25683632
[TBL] [Abstract][Full Text] [Related]
2. Increasing trends in the incidence and prevalence rates of type 1 diabetes among children and adolescents in the Netherlands.
Fazeli Farsani S; Souverein PC; van der Vorst MM; Knibbe CA; Herings RM; de Boer A; Mantel-Teeuwisse AK
Pediatr Diabetes; 2016 Feb; 17(1):44-52. PubMed ID: 25377748
[TBL] [Abstract][Full Text] [Related]
3. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
[TBL] [Abstract][Full Text] [Related]
4. Trends in the use of oral antidiabetic drugs by outpatients in Taiwan: 1997-2003.
Chiang CW; Chiu HF; Chen CY; Wu HL; Yang CY
J Clin Pharm Ther; 2006 Feb; 31(1):73-82. PubMed ID: 16476123
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
6. Association between use of oral-antidiabetic drugs and the risk of aortic aneurysm: a nested case-control analysis.
Hsu CY; Su YW; Chen YT; Tsai SH; Chang CC; Li SY; Huang PH; Chen JW; Lin SJ
Cardiovasc Diabetol; 2016 Sep; 15(1):125. PubMed ID: 27585542
[TBL] [Abstract][Full Text] [Related]
7. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
[TBL] [Abstract][Full Text] [Related]
8. Time trends in the incidence, prevalence and age at diagnosis of asthma in children.
Engelkes M; Janssens HM; de Ridder MA; de Jongste JC; Sturkenboom MC; Verhamme KM
Pediatr Allergy Immunol; 2015 Jun; 26(4):367-74. PubMed ID: 25827225
[TBL] [Abstract][Full Text] [Related]
9. No increase in new users of blood glucose-lowering drugs in Norway 2006-2011: a nationwide prescription database study.
Strøm H; Selmer R; Birkeland KI; Schirmer H; Berg TJ; Jenum AK; Midthjell K; Berg C; Stene LC
BMC Public Health; 2014 May; 14():520. PubMed ID: 24886413
[TBL] [Abstract][Full Text] [Related]
10. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
Oladapo AO; Barner JC; Rascati KL; Strassels SA
Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular medication use and cardiovascular disease in children and adolescents with type 1 diabetes: a population-based cohort study.
Ahmadizar F; Fazeli Farsani S; Souverein PC; van der Vorst MM; de Boer A; Maitland-van der Zee AH
Pediatr Diabetes; 2016 Sep; 17(6):433-40. PubMed ID: 26260711
[TBL] [Abstract][Full Text] [Related]
12. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
13. Persistence patterns with oral antidiabetes drug treatment in newly treated patients--a population-based study.
Grégoire JP; Sirois C; Blanc G; Poirier P; Moisan J
Value Health; 2010; 13(6):820-8. PubMed ID: 21054658
[TBL] [Abstract][Full Text] [Related]
14. Difficulty adhering to antidiabetic treatment: factors associated with persistence and compliance.
Guénette L; Moisan J; Breton MC; Sirois C; Grégoire JP
Diabetes Metab; 2013 May; 39(3):250-7. PubMed ID: 23523643
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Young People With Antipsychotic Medications in the United States.
Olfson M; King M; Schoenbaum M
JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
[TBL] [Abstract][Full Text] [Related]
16. Estimation of incidence and prevalence of Parkinson's disease in the elderly using pharmacy records.
van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
Pharmacoepidemiol Drug Saf; 2001; 10(6):549-54. PubMed ID: 11828838
[TBL] [Abstract][Full Text] [Related]
17. Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?
Mantel-Teeuwisse AK; Klungel OH; Verschuren WM; Porsius AJ; de Boer A
Br J Clin Pharmacol; 2002 Apr; 53(4):379-85. PubMed ID: 11966669
[TBL] [Abstract][Full Text] [Related]
18. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
[TBL] [Abstract][Full Text] [Related]
19. Twelve-month frequency of drug-metabolizing enzyme and transporter-based drug-drug interaction potential in patients receiving oral enzyme-targeted kinase inhibitor antineoplastic agents.
Bowlin SJ; Xia F; Wang W; Robinson KD; Stanek EJ
Mayo Clin Proc; 2013 Feb; 88(2):139-48. PubMed ID: 23374617
[TBL] [Abstract][Full Text] [Related]
20. An increase in the prevalence of type 1 and 2 diabetes in children and adolescents: results from prescription data from a UK general practice database.
Hsia Y; Neubert AC; Rani F; Viner RM; Hindmarsh PC; Wong IC
Br J Clin Pharmacol; 2009 Feb; 67(2):242-9. PubMed ID: 19260863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
